Elutia (ELUT) Shares Outstanding (Weighted Average) (2019 - 2026)
Elutia recorded quarterly Shares Outstanding (Weighted Average) of $43.0 million in Q1 2026, up 8858.02% quarter-over-quarter from $480000.0 in Q4 2025, and up 11.35% year-over-year from $38.6 million in Q1 2025.
Elutia's Shares Outstanding (Weighted Average) history runs 8 years deep, the most recent figure standing at $43.0 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 11.35% year-over-year to $43.0 million; the TTM figure through Mar 2026 stood at $43.0 million (up 11.35% YoY), while the FY2025 annual figure was $480000.0, down 98.35% from the prior year.
- Shares Outstanding (Weighted Average) came in at $43.0 million for Q1 2026 at Elutia, up from $480000.0 in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $43.0 million in Q1 2026 to a low of $480000.0 in Q4 2025.
- A 5-year average of $21.9 million and a median of $17.0 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
- Across the five-year window, Shares Outstanding (Weighted Average) surged 5678.88% in 2024 and sank 98.35% in 2025, its largest moves.
- Elutia's Shares Outstanding (Weighted Average) stood at $13.8 million in 2022, then tumbled by 96.36% to $503058.0 in 2023, then soared by 5678.88% to $29.1 million in 2024, then tumbled by 98.35% to $480000.0 in 2025, then jumped by 8858.02% to $43.0 million in 2026.
- According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $43.0 million, $480000.0, and $41.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn | 43.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.00 Mn |
| Dec 31, 2025 | 41.42 Mn |
| Sep 30, 2025 | 42.43 Mn |
| Jun 30, 2025 | 40.24 Mn |
| Mar 31, 2025 | 38.62 Mn |
| Dec 31, 2024 | 29.07 Mn |
| Sep 30, 2024 | 27.13 Mn |
| Jun 30, 2024 | 24.41 Mn |
| Mar 31, 2024 | 23.91 Mn |
| Dec 31, 2023 | 503,058.00 |
| Sep 30, 2023 | 17.02 Mn |
| Jun 30, 2023 | 16.22 Mn |
| Mar 31, 2023 | 16.15 Mn |
| Dec 31, 2022 | 13.83 Mn |
| Sep 30, 2022 | 13.62 Mn |
| Jun 30, 2022 | 13.62 Mn |
| Mar 31, 2022 | 13.57 Mn |
| Dec 31, 2021 | 10.44 Mn |
| Sep 30, 2021 | 10.23 Mn |
| Jun 30, 2021 | 10.23 Mn |
| Mar 31, 2021 | 10.23 Mn |
| Dec 31, 2020 | 2.85 Mn |
| Sep 30, 2020 | 648,331.00 |
| Jun 30, 2020 | 648,277.00 |
| Mar 31, 2020 | 648,277.00 |
| Dec 31, 2019 | 645,994.00 |
| Sep 30, 2019 | 645,142.00 |